• Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page

John retiring


<







John retiring: Good!
The next CEO coming from within Lilly: Bad!

We can all look forward to more of the same failed policies.

It only matters what the geniuses on Wall Street think (if you can legitimately say they actually think at all). Just as long as the stock price stays overinflated until he cashes in on all his options, then crash!
 
















e79c5eccc688b742d68ffce6799fcc2a.jpg

My glasses make me feel awkward and plain...
 








He should be put on a wall of shame for crimes against loyal hardworking employees whose discharge was a way to simply prop up quarterly earnings with phony acvounting tricks
 








































What a bunch of anonymous whiners. I knew/know John. I like him. Think you could do better? Walk in his Ferragamoze before you criticize. It ain't easy being chief. Lot of competing problems you don't have to deal with.